Thermo Fisher Scientific Inc.
TMO
TMO
Thermo Fisher Scientific was featured in CNBC's 'Final Trades' segment reported by Benzinga. The company holds a market capitalization of approximately 228.09 billion USD and generated 44.556 billion USD in full-year revenue. It currently trades at a PE ratio of 32.96, with a TTM EPS of 18.81 and a free cash flow yield of 3.21%.
Based on benzinga.comWhat Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
Pfizer, Thermo Fisher Scientific And More: CNBC's ‘Final Trades'
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
How to Invest in AI Drug Discovery
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.